June 15, 2018: Research at Scale – Exploring What is Possible with High-Quality Real-World Data. Examples from Flatiron Health. (Amy P. Abernethy MD, MPH)

Speaker

Amy P. Abernethy MD, MPH
Chief Medical Officer, Chief Scientific Officer, SVP Oncology
Flatiron Health

Topic

Research at Scale – Exploring What is Possible with High-Quality Real-World Data. Examples from Flatiron Health.

Keywords

Clinical research; Clinical trials; Health data; Cancer research; Flatiron health; Real-world evidence; High-quality data; Real-world data

Key Points

  • Flatiron Health is evaluating the emerging role of data and technology to reimagine the clinical trials process from design through execution. Their technology is standardizing electronic health record data to a common data model, enabling millions of electronic health records in a single common dataset.
  • The 21st Century Cures Act presents an opportunity to use regulatory-grade real-world evidence. Characteristics of real-world data and real-world evidence have the potential to improve the clinical depth and completeness of health data as well as scalability and generalizability.

Discussion Themes

The addition of other linked datasets will provide a broader set of data and contribute to the expansion of use for other systems. The more datasets, the more “triangular” the sets will become. The more that high-quality real-world datasets are used in concert, the better.

Linkage to data claims is an integral piece of the high-quality real-world data puzzle. With large portions of oncological data, necessary records can be abstracted, providing simplicity in linking.

 

Tags

@Collaboratory1, @dramyabernethy, @flatironhealth, #clinicaltrials, #pctGR, #realworldevidence, #cancerresearch, #oncologist, #healthdata